Literature DB >> 11823817

Nerve inflammation halts trial for Alzheimer's drug.

Erika Check.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823817     DOI: 10.1038/415462a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  52 in total

1.  Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model.

Authors:  Ken-ichiro Fukuchi; Mary Ann Accavitti-Loper; Hong-Duck Kim; Kazuki Tahara; Yunpeng Cao; Terry L Lewis; Robert C Caughey; Helen Kim; Robert Lalonde
Journal:  Biochem Biophys Res Commun       Date:  2006-05-26       Impact factor: 3.575

2.  Vaccine trial in Alzheimer's disease is halted.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

3.  FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.

Authors:  Tomomi Kiyota; Kaitlin L Ingraham; Michael T Jacobsen; Huangui Xiong; Tsuneya Ikezu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

Review 4.  The regulation of AβPP expression by RNA-binding proteins.

Authors:  Cara J Westmark; James S Malter
Journal:  Ageing Res Rev       Date:  2012-04-05       Impact factor: 10.895

Review 5.  Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Authors:  Daniela Puzzo; Ottavio Arancio
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  N-terminal engineering of amyloid-β-binding Affibody molecules yields improved chemical synthesis and higher binding affinity.

Authors:  Joel Lindgren; Anna Wahlström; Jens Danielsson; Natalia Markova; Caroline Ekblad; Astrid Gräslund; Lars Abrahmsén; Amelie Eriksson Karlström; Sebastian K T S Wärmländer
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

7.  Determination of primary structure and microheterogeneity of a beta-amyloid plaque-specific antibody using high-performance LC-tandem mass spectrometry.

Authors:  Irina Perdivara; Leesa Deterding; Adrian Moise; Kenneth B Tomer; Michael Przybylski
Journal:  Anal Bioanal Chem       Date:  2008-03-28       Impact factor: 4.142

Review 8.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

Review 9.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

10.  Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.

Authors:  Jan G Schiltz; Ulrich Salzer; M Hasan Mohajeri; Daniel Franke; Jochen Heinrich; Jovan Pavlovic; M Axel Wollmer; Roger M Nitsch; Karin Moelling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.